The MarketWatch News Department was not involved in the creation of this content.
Apr 05, 2023 (The Expresswire) --Latest Research Report 2023-2028: “Invasive Fungal Infection Market” | Survey with 124 Pages Report
The Invasive Fungal Infection Market has experienced rapid growth in recent times, largely worked by the rising demand for products and services falling under categories like [Diagnosis , Treatment ] and Applications [Yeast-like Fungi , Filamentous Fungi ]. This market report provides a comprehensive overview of the market's structure, revenue streams, and competitive landscape, offering valuable insights into future scenarios and emerging trends. By analyzing key players from a bottom-up perspective, the report offers current and accurate information on market size, shares, and industry segmentation details. The Invasive Fungal Infection Market is expected to sustain its growth trajectory, as current trends continue to drive innovation and expansion while opening up new opportunities for market players.
Get a sample PDF of the report at - https://www.marketresearchguru.com/enquiry/request-sample/19102271
Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.
Market Analysis and Insights: Global Invasive Fungal Infection Market
In 2021, the global Invasive Fungal Infection market size will be USD million and it is expected to reach USD million by the end of 2027, with a CAGR of Percent during 2021-2027.
Some of the prominent players reviewed in the research report include:
The information for each competitor includes, Company Profile, Main Business Information, SWOT Analysis, Sales, Revenue, Price and Gross Margin, Market Share, etc.
● Cidara Therapeutics
● Basilea Pharmaceutica
● Pfizer
● GlaxoSmithKline
● Bayer
● Abbott
● Merck
● Astellas Pharma
● F2G
● Scynexis
● Associates of Cape Cod
● BioRad
● IMMY
● Beijing Jinshanchuan
● Danna Biological
● Zhanjiang A and C Biological
Get Sample Copy of Invasive Fungal Infection Market Report
Scope of Invasive Fungal Infection Market:
● The report shares our perspectives for the impact of COVID-19 from the long and short term.
● The report provides the influence of the crisis on the industry chain, especially for marketing channels.
● The report updates the timely industry economic revitalization plan of the country-wise government.
On the basis of product type, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
● Diagnosis
● Treatment
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
● Yeast-like Fungi
● Filamentous Fungi
● Other
Inquire or Share Your Questions If Any Before the Purchasing This Report - https://www.marketresearchguru.com/enquiry/pre-order-enquiry/19102271
COVID-19 and Russia-Ukraine War Influence Analysis:
The readers in the section will understand how the Invasive Fungal Infection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Purchase this Report -
● Analysing the outlook of the market with the recent trends and SWOT analysis.
● Market dynamics scenario, along with growth opportunities of the market in the years to come.
● Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects.
● Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
● Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
● Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past years.
● Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.
To Understand How Covid-19 Impact Is Covered in This Report - https://marketresearchguru.com/enquiry/request-covid19/19102271
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast of the following regions are covered:
● North America
● Europe
● Asia-Pacific
● Middle East and Africa
● South America
Core Chapters:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Invasive Fungal Infection manufacturers competitive landscape, price, output and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Invasive Fungal Infection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Invasive Fungal Infection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 5: Provides the analysis of various market segments according to product type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, revenue, , price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Analysis of sales channel, distributors and customers
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: Production and supply forecast, global and regional
Chapter 12: Consumption and demand forecast, global and regional
Chapter 13: Forecast by type and by application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 14: The main points and conclusions of the report.
Purchase this Report (Price 3900 USD for a Single-User License) -https://marketresearchguru.com/purchase/19102271
Main Points from Table of Contents:
1 Invasive Fungal Infection Market Overview
1.1 Product Overview and Scope of Invasive Fungal Infection
1.2 Invasive Fungal Infection Segment by Type
1.3 Invasive Fungal Infection Segment by Application
1.4 Global Market Growth Prospect
1.5 Global Market Size by Region
2 Market Competition by Manufacturers
2.1 Global Invasive Fungal Infection Production Market Share by Manufacturers
2.2 Global Invasive Fungal Infection Revenue Market Share by Manufacturers
2.3 Invasive Fungal Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Invasive Fungal Infection Average Price by Manufacturers
2.5 Manufacturers Invasive Fungal Infection Production Sites, Area Served, Product Types
2.6 Invasive Fungal Infection Market Competitive Situation and Trends
3 Production by Region
3.1 Global Production of Invasive Fungal Infection Market Share by Region
3.4 North America Invasive Fungal Infection Production
3.5 Europe Invasive Fungal Infection Production
3.6 China Invasive Fungal Infection Production
3.7 Japan Invasive Fungal Infection Production
4 Global Invasive Fungal Infection Consumption by Region
4.1 Global Invasive Fungal Infection Consumption by Region
4.2 North America
4.3 Europe
4.4 Asia Pacific
4.5 Latin America
5 Segment by Type
5.1 Global Production Market Share by Type
5.2 Global Revenue Market Share by Type
5.3 Global Price by Type
6 Segment by Application
6.1 Global Production Market Share by Application
6.2 Global Revenue Market Share by Application
6.3 Global Price by Application
7 Key Companies Profiled
8 Invasive Fungal Infection Manufacturing Cost Analysis
8.1 Key Raw Materials Analysis
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Invasive Fungal Infection
8.4 Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Distributors List
9.3 Customers
10 Market Dynamics
10.1 Invasive Fungal Infection Industry Trends
10.2 Invasive Fungal Infection Market Drivers
10.3 Invasive Fungal Infection Market Challenges
10.4 Invasive Fungal Infection Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Invasive Fungal Infection by Region
11.2 North America Production, Revenue Forecast
11.3 Europe Production, Revenue Forecast
11.4 China Production, Revenue Forecast
11.5 Japan Production, Revenue Forecast
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Invasive Fungal Infection
12.2 North America Forecasted Consumption of by Country
12.3 Europe Market Forecasted Consumption of by Country
12.4 Asia Pacific Market Forecasted Consumption of by Region
12.5 Latin America Forecasted Consumption of by Country
13 Forecast by Type and by Application
13.1 Global Production, Revenue and Price Forecast by Type
13.2 Global Forecasted Consumption of Invasive Fungal Infection by Application
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
For Detailed TOC - https://marketresearchguru.com/TOC/19102271#TOC
Contact Us:
Market Research Guru
Phone: US +14242530807
UK +44 20 3239 8187
Email: sales@marketresearchguru.com
Web: https://www.marketresearchguru.com
Our Other Reports:-
Mold Inhibitors Market
Analytics and Technology Market
[2023-2028] Racks for Boat Dry Storage Market
Digital Transformation Consulting Market
Ready-to-drink (RTD) Coffee Market
ITSM Market
Circulating Tumor Cells (CTC) Market
HEDTA Market
Impermeable Carbon Graphite Market
Small Gas Engines Market
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit 2023-2028 Invasive Fungal Infection Market by Types and Application |Extensive Research
COMTEX_428405871/2598/2023-04-05T03:29:00
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
FAQs
What is considered an invasive fungal infection? ›
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body.
How is invasive fungal infection diagnosed? ›The most common way that healthcare providers test for invasive candidiasis is by taking a blood sample or sample from the infected body site and sending it to a laboratory to see if it will grow Candida in a culture.
What is the prevalence of invasive aspergillosis in India? ›Invasive aspergillosis.
The annual incidence of invasive aspergillosis in India is an estimated 250,900 cases, including 79,100 to 239,000 cases in people with chronic obstructive pulmonary disease; 1,885 cases in people with lung cancer; and 7,040 cases in people with leukemia, lymphoma, or transplantation.
...
Examples of fungal infections
- Athlete's foot.
- Vaginal yeast infection.
- “Jock itch”
- Ringworm.
For most adults, the initial recommended antifungal treatment is an echinocandin (caspofungin, micafungin, or anidulafungin) given through the vein (intravenous or IV). Fluconazole, amphotericin B, and other antifungal medications may also be appropriate in certain situations.
What is the most common cause of invasive fungal infection? ›The most common cause of invasive candidiasis is Candida albicans.
Who are most at risk of invasive fungal infections? ›Populations at greatest risk of invasive fungal infections include those with cancer, HIV/AIDS, organ transplants, chronic respiratory disease, and post-primary tuberculosis infection.
Who is at high risk for invasive aspergillosis? ›Invasive aspergillosis affects people who have weakened immune systems, such as people who have had a stem cell transplant or organ transplant, are getting chemotherapy for cancer, or are taking high doses of corticosteroids.
Who is the most common victim of aspergillosis? ›Allergic bronchopulmonary aspergillosis is more likely to occur in individuals who have asthma or cystic fibrosis.
What is the most common site of invasive aspergillosis? ›Invasive aspergillosis: Occurs when Aspergillus causes a serious infection, and usually affects people who have weakened immune systems, such as people who have had an organ transplant or a stem cell transplant. Invasive aspergillosis most commonly affects the lungs, but it can also spread to other parts of the body.
How do you get rid of fungus inside your body? ›
- Eat Yoghurt and Probiotics. Yoghurt and other probiotics have an ample amount of good bacteria that help stave off many fungal infections. ...
- Wash with Soap and Water. ...
- Use Apple Cider Vinegar. ...
- Use Tea Tree Oil. ...
- Use Coconut Oil. ...
- Use Turmeric. ...
- Use Aloe Vera. ...
- Garlic.
Ophiocordyceps, the fungus from 'The Last Of Us,' is real. But is it as deadly? This species of fungus, Ophiocordyceps, is known for using "mind control" on insect hosts. Humans, however, are immune.
What is the next pandemic fungus? ›Candida auris (C. auris), an emerging fungus considered an urgent antimicrobial resistance (AR) threat, spread at an alarming rate in U.S. healthcare facilities in 2020-2021, according to data from the Centers for Disease Control and Prevention (CDC) published in the Annals of Internal Medicine.
What is the most invasive fungus? ›But the globe's deadliest invasive is invisible to the naked eye—the chytrid fungus. That's the conclusion of a new study, published Thursday in Science, which quantified the global death toll of the amphibian-killing fungus.
What is strongest medication for fungal infection? ›- clotrimazole (Canesten)
- econazole.
- miconazole.
- terbinafine (Lamisil)
- fluconazole (Diflucan)
- ketoconazole (Daktarin)
- nystatin (Nystan)
- amphotericin.
- Cutting back on unhelpful foods. As we've already seen, eating refined, high-sugar foods allows Candida to thrive. ...
- Focusing on sleep, exercise, and stress reduction. ...
- Using supplements. ...
- Adding medication when needed.
If left completely untreated, your stubborn fungal skin infection may cause some or the other kind of permanent damage and in some cases your fungal infection may eventually lead to death.
Can fungal infection affect brain? ›Fungal meningitis can develop after a fungal infection spreads from somewhere else in the body to the brain or spinal cord. Some causes of fungal meningitis include Cryptococcus, Histoplasma, Blastomyces, Coccidioides, and Candida.
What is the most common deep systemic fungal infection in USA? ›Candida is the most common pathogen of deep fungal infections (3). It is widely found in human skin and mucous membranes and is usually maintained as a benign colonization state.
What are 3 common fungal infections? ›Fungal skin infections can happen anywhere on your body. Some of the most common are athlete's foot, jock itch, ringworm, and yeast infections.
Can invasive fungal infections lead to sepsis? ›
Candida albicans is a major cause of bloodstream infection which may present as sepsis and septic shock - major causes of morbidity and mortality world-wide. After invasion of the pathogen, innate mechanisms govern the early response.
What is one of the most common fungal infection acquired in the hospital? ›In the United States, one of the most common bloodstream infections acquired in the hospital is caused by a fungus called Candida. Candida normally lives in the gastrointestinal tract and on skin without causing any problems, but it can enter the bloodstream and cause infection.
How do people get fungal infections? ›Anyone can get a fungal infection, even people who are otherwise healthy. Fungi are common in the environment, and people breathe in or come in contact with fungal spores every day without getting sick. However, in people with weakened immune systems, these fungi are more likely to cause an infection.
What are examples of invasive fungus? ›The most common medically important fungal pathogens in resource-rich healthcare settings are Aspergillus spp and Candida spp. From a global perspective, Cryptococcus neoformans is a leading cause of infectious morbidity and mortality, with an estimated 600,000 deaths per year.
What is an example of invasive fungi? ›Globally, hundreds of thousands of people are affected every year with Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Pneumocystis jirovecii, endemic dimorphic fungi and Mucormycetes, the most common fungal species causing invasive diseases in humans.
What is the difference between invasive and noninvasive fungal infection? ›Providers classify fungal sinus infections as invasive and noninvasive. Invasive infections can spread to other areas, such as the eyes and brain. Noninvasive sinus infections, the more common type, only affect the nose and sinus areas.
What is the most common deep fungal infection in USA? ›Candida is the most common pathogen of deep fungal infections (3). It is widely found in human skin and mucous membranes and is usually maintained as a benign colonization state.
What are the deadliest fungal diseases in humans? ›The fungus, a type of yeast called Candida auris, or C. auris, can cause severe illness in people with weakened immune systems.
What are three harmful fungi examples? ›Harmful Fungi
Five species of molds - aspergillus, fusarium, lomentospora, scedosporium and mucormycetes - have been identified as “killers of humans”. Oral thrush and diaper rash are caused by the yeast Candida albicans.
Systemic fungal infections can affect the skin and organs such as the lungs, eyes, liver, and brain and typically occur in immunocompromised hosts (see Opportunistic fungal infections. Primary infections can develop in immunocompetent... read more ).
What is the invasive fungus in North America? ›
Many species of ectomycorrhizal (EM) fungi have been introduced across and among continents, but with this evidence, the death cap becomes the only known invasive EM fungus in North America.
Who treats invasive fungal infections? ›These infections require care from expert infectious disease specialists.
What is the mortality of invasive fungal infection? ›Fungal pathogens are responsible for at least 13 million infections and 1.5 million deaths globally per year, primarily in those with some compromised immune function [1].
Which of the following antifungal drugs is most effective in the treatment of invasive? ›Posaconazole has approval for prophylaxis of both invasive aspergillosis and invasive candidiasis. Additionally, posaconazole is used to treat oropharyngeal candidiasis, typically for patient populations refractory to treatment with fluconazole and itraconazole.